Integrated Diagnostics Holdings (IDGXF) Ratios
Integrated Diagnostics Holdings Ratios
IDGXF's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, IDGXF's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.46 | 1.42 | 1.54 | 1.11 | 1.30 |
| Quick Ratio | 1.31 | 1.28 | 1.24 | 0.93 | 1.20 |
| Cash Ratio | 0.62 | 0.55 | 0.53 | 0.44 | 0.38 |
| Solvency Ratio | 0.41 | 0.43 | 0.34 | 0.30 | 0.48 |
| Operating Cash Flow Ratio | 0.71 | 0.72 | 0.43 | 0.14 | 0.97 |
| Short-Term Operating Cash Flow Coverage | 10.95 | 6.99 | 12.45 | 9.21 | 104.50 |
| Net Current Asset Value | $ -513.00M | $ -549.51M | $ -707.14M | $ -1.22B | $ -399.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.21 | 0.20 | 0.22 | 0.14 |
| Debt-to-Equity Ratio | 0.48 | 0.54 | 0.44 | 0.55 | 0.33 |
| Debt-to-Capital Ratio | 0.32 | 0.35 | 0.31 | 0.35 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.01 | 0.02 | 0.04 | 0.03 |
| Financial Leverage Ratio | 2.54 | 2.63 | 2.15 | 2.46 | 2.41 |
| Debt Service Coverage Ratio | 5.43 | 4.21 | 5.46 | 6.65 | 15.28 |
| Interest Coverage Ratio | 10.19 | 7.12 | 5.21 | 6.78 | 23.08 |
| Debt to Market Cap | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Interest Debt Per Share | 3.13 | 2.77 | 2.20 | 2.17 | 1.59 |
| Net Debt to EBITDA | -0.02 | 0.14 | 0.39 | 0.41 | -0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.69% | 38.14% | 36.98% | 40.56% | 53.67% |
| EBIT Margin | 29.62% | 28.15% | 21.32% | 27.08% | 44.60% |
| EBITDA Margin | 36.82% | 36.59% | 31.06% | 35.88% | 49.17% |
| Operating Profit Margin | 27.05% | 21.23% | 17.90% | 23.08% | 43.30% |
| Pretax Profit Margin | 26.97% | 25.17% | 17.89% | 23.68% | 42.73% |
| Net Profit Margin | 16.07% | 18.84% | 12.38% | 15.01% | 27.04% |
| Continuous Operations Profit Margin | 16.57% | 17.63% | 11.36% | 14.61% | 28.57% |
| Net Income Per EBT | 59.58% | 74.84% | 69.21% | 63.39% | 63.28% |
| EBT Per EBIT | 99.72% | 118.55% | 99.94% | 102.58% | 98.69% |
| Return on Assets (ROA) | 14.69% | 15.11% | 8.84% | 10.22% | 22.65% |
| Return on Equity (ROE) | 37.31% | 39.76% | 19.05% | 25.12% | 54.69% |
| Return on Capital Employed (ROCE) | 36.02% | 24.46% | 16.41% | 21.72% | 58.19% |
| Return on Invested Capital (ROIC) | 20.67% | 15.68% | 9.94% | 12.83% | 37.58% |
| Return on Tangible Assets | 18.72% | 20.24% | 12.57% | 15.06% | 30.86% |
| Earnings Yield | 6.12% | 8.18% | 7.77% | 5.76% | 11.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.13 | 6.15 | 6.02 | 9.07 | 13.97 |
| Payables Turnover | 7.99 | 11.05 | 9.56 | 7.94 | 7.78 |
| Inventory Turnover | 10.61 | 11.14 | 6.93 | 8.07 | 10.87 |
| Fixed Asset Turnover | 2.81 | 2.55 | 1.97 | 1.85 | 3.43 |
| Asset Turnover | 0.91 | 0.80 | 0.71 | 0.68 | 0.84 |
| Working Capital Turnover Ratio | 7.24 | 7.13 | 9.73 | 8.44 | 10.00 |
| Cash Conversion Cycle | 48.24 | 59.11 | 75.11 | 39.51 | 12.74 |
| Days of Sales Outstanding | 59.51 | 59.37 | 60.65 | 40.25 | 26.12 |
| Days of Inventory Outstanding | 34.41 | 32.76 | 52.63 | 45.21 | 33.57 |
| Days of Payables Outstanding | 45.68 | 33.02 | 38.18 | 45.95 | 46.94 |
| Operating Cycle | 93.92 | 92.13 | 113.29 | 85.46 | 59.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.28 | 2.64 | 0.91 | 0.35 | 3.78 |
| Free Cash Flow Per Share | 2.38 | 2.26 | 0.36 | -0.17 | 3.34 |
| Dividend Paid and CapEx Coverage Ratio | 1.80 | 6.22 | 1.67 | 0.12 | 3.06 |
| Capital Expenditure Coverage Ratio | 3.66 | 6.98 | 1.67 | 0.68 | 8.61 |
| Operating Cash Flow Coverage Ratio | 1.18 | 1.07 | 0.46 | 0.18 | 2.64 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.27 | 0.13 | 0.06 | 0.43 |
| Free Cash Flow Yield | 6.70% | 10.20% | 3.31% | -1.07% | 16.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.36 | 12.20 | 12.88 | 17.36 | 8.58 |
| Price-to-Sales (P/S) Ratio | 2.63 | 2.30 | 1.59 | 2.61 | 2.32 |
| Price-to-Book (P/B) Ratio | 6.10 | 4.86 | 2.45 | 4.36 | 4.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.92 | 9.80 | 30.18 | -93.82 | 6.04 |
| Price-to-Operating Cash Flow Ratio | 10.84 | 8.40 | 12.09 | 45.00 | 5.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.85 | 0.11 | -2.32 | -0.28 | 0.06 |
| Enterprise Value Multiple | 7.12 | 6.43 | 5.53 | 7.67 | 4.71 |
| Enterprise Value | 20.58B | 13.46B | 7.08B | 9.92B | 12.09B |
| EV to EBITDA | 7.12 | 6.43 | 5.53 | 7.67 | 4.71 |
| EV to Sales | 2.62 | 2.35 | 1.72 | 2.75 | 2.31 |
| EV to Free Cash Flow | 14.88 | 10.01 | 32.50 | -99.12 | 6.03 |
| EV to Operating Cash Flow | 10.81 | 8.58 | 13.02 | 47.54 | 5.33 |
| Tangible Book Value Per Share | 3.92 | 2.85 | 2.32 | 1.24 | 1.89 |
| Shareholders’ Equity Per Share | 5.82 | 4.57 | 4.46 | 3.59 | 4.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.39 | 0.30 | 0.36 | 0.38 | 0.33 |
| Revenue Per Share | 13.51 | 9.64 | 6.87 | 6.01 | 8.71 |
| Net Income Per Share | 2.17 | 1.82 | 0.85 | 0.90 | 2.35 |
| Tax Burden | 0.60 | 0.75 | 0.69 | 0.63 | 0.63 |
| Interest Burden | 0.91 | 0.89 | 0.84 | 0.87 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.09 | 0.06 | 0.06 | 0.04 |
| Stock-Based Compensation to Revenue | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Income Quality | 0.90 | 1.09 | 0.74 | 0.24 | 1.02 |
Currency in 67
